Standout Papers

Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients wit... 2015 2026 2018 2022 536
  1. Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial (2015)
    Jin Li, Shukui Qin et al. The Lancet Oncology

Immediate Impact

9 by Nobel laureates 25 from Science/Nature 67 standout
Sub-graph 1 of 21

Citing Papers

AARS1 and AARS2 sense l-lactate to regulate cGAS as global lysine lactyltransferases
2024 StandoutNature
Colorectal cancer
2024 Standout
1 intermediate paper

Works of Liwei Wang being referenced

Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial
2015 Standout
Suppressed expression of LDHB promotes pancreatic cancer progression via inducing glycolytic phenotype
2015

Author Peers

Author Last Decade Papers Cites
Liwei Wang 1994 1873 759 820 109 3.8k
Susumu Saigusa 1466 1350 591 1070 120 3.2k
Karim A. Benhadji 2041 1738 516 524 116 3.6k
Michio Sowa 1353 1644 933 735 183 3.4k
Yang Lü 1849 1916 955 896 165 4.4k
Paola Ulivi 1681 1462 1262 1321 178 3.6k
Wei-Shone Chen 1698 1047 684 624 105 3.0k
Gerrit Los 1653 1797 1013 420 94 4.1k
Susana Roselló 2165 850 952 812 88 3.4k
Simon Thézenas 1644 817 770 709 117 2.9k
Paul Frankel 1910 1725 938 645 212 4.0k

All Works

Loading papers...

Rankless by CCL
2026